Since establishing our private equity strategy in 1989, we have invested in over 350 private equity investments in 41 countries.
|Company||Country||Sector||Description||Deal type||Invest. date|
|Transcend Therapeutics||Country US||Sector Healthcare||Description Company formed to develop novel pharmaceuticals for the critical-care market||Deal type Growth equity||Invest. date Apr 1994|
|Telik||Country US||Sector Healthcare||Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics)||Deal type Growth equity||Invest. date Nov 1994|
|Genoa Healthcare||Country US||Sector Healthcare||Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community||Deal type Buyout||Invest. date Apr 2015|
|3i - Implant Innovations Inc.||Country US||Sector Healthcare||Description Manufacturer of dental implants||Deal type Growth equity||Invest. date May 1995|